Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹991 Cr
Revenue (TTM)
₹216 Cr
Net Profit (TTM)
₹36 Cr
ROE
11.3 %
ROCE
13.1 %
P/E Ratio
27.2
P/B Ratio
2
Industry P/E
24.59
EV/EBITDA
16.4
Div. Yield
0.6 %
Debt to Equity
0.1
Book Value
₹201
EPS
₹76.2
Face value
5
Shares outstanding
24,656,912
CFO
₹315.50 Cr
EBITDA
₹445.21 Cr
Net Profit
₹351.35 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Paushak
| -32.7 | -22.6 | -32.9 | -- | -- | -- | -- |
|
BSE Commodities
| -4.5 | -7.1 | -2.0 | 6.4 | 15.2 | 12.8 | 16.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Paushak
|
400.2 | 991.3 | 215.8 | 36.4 | 19.8 | 7.7 | 27.2 | 2.0 |
| 6,245.0 | 18,368.7 | 6,055.1 | 602.4 | 10.7 | 10.3 | 30.9 | 3.0 | |
| 1,041.0 | 16,288.2 | 13,910.2 | 664.1 | 7.7 | 9.8 | 24.6 | 2.2 | |
| 789.1 | 14,041.3 | 37,474.8 | 2,223.8 | 7.2 | 12.8 | 11.8 | 1.5 | |
| 5,247.0 | 3,938.5 | 604.0 | 75.2 | 15.9 | 11.6 | 54.5 | -- | |
| 57.2 | 2,593.1 | 1,175.2 | 140.3 | 11.9 | 14.5 | 18.5 | 2.5 | |
| 876.3 | 5,867.5 | 9,655.3 | 225.1 | 5.0 | 11.6 | 21.7 | 2.0 | |
| 487.2 | 3,012.2 | 2,135.4 | 129.9 | 10.9 | 31.4 | 23.2 | 6.3 | |
| 453.1 | 3,969.9 | 1,769.1 | 104.7 | 10.5 | 24.3 | 37.9 | 8.1 | |
| 1,336.4 | 3,519.8 | 818.2 | 19.4 | 12.6 | 3.7 | 178.4 | 4.4 |
Paushak Limited develops, manufactures, and sells phosgene based specialty chemicals and intermediates in India and internationally. Its products include isocyanates, chloroformates, carbonates/carbamates, carbamoyl chlorides, and others. The company... primarily serves pharma, agro, and specialty chemical companies. Paushak Limited was incorporated in 1972 and is based in Vadodara, India. Read more
Incorporated
1972
Chairman
Chirayu Amin
Managing Director
--
Group
Alembic
Headquarters
Vadodara, Gujarat
Website
Looking for more details about Paushak Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Paushak Ltd is ₹400.15 (NSE) and ₹402.05 (BSE) as of 20-Mar-2026 IST. Paushak Ltd has given a return of --% in the last 1 years.
The P/E ratio of Paushak Ltd is 27.23 times as on 20-Mar-2026, a 11 premium to its peers’ median range of 24.59 times.
The P/B ratio of Paushak Ltd is 2.00 times as on 20-Mar-2026, a 9 discount to its peers’ median range of 2.19 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
28.19
|
2.99
|
|
2024
|
28.91
|
3.85
|
|
2023
|
35.48
|
5.42
|
|
2022
|
85.18
|
10.48
|
|
2021
|
69.06
|
9.48
|
The 52-week high and low of Paushak Ltd are Rs 633.05 and Rs 397.00 as of 21-Mar-2026.
Paushak Ltd has a market capitalisation of ₹ 991 Cr as on 20-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Paushak Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-0.50
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.